The novel therapy of this peptide represents a major advance in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide242528.thechapblog.com/40801480/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment